HomeCompareSYK vs LDOS

SYK vs LDOS: Dividend Comparison 2026

SYK yields 1.04% · LDOS yields 1.08%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SYK wins by $20.1K in total portfolio value
10 years
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →
LDOS
LDOS
● Live price
1.08%
Share price
$154.19
Annual div
$1.66
5Y div CAGR
15.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.2K
Annual income
$520.20
Full LDOS calculator →

Portfolio growth — SYK vs LDOS

📍 SYK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSYKLDOS
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SYK + LDOS cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SYK pays
LDOS pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
LDOS
Annual income on $10K today (after 15% tax)
$91.51/yr
After 10yr DRIP, annual income (after tax)
$442.17/yr
At 15% tax rate, SYK beats the other by $6,598.36/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYK + LDOS for your $10,000?

SYK: 50%LDOS: 50%
100% LDOS50/50100% SYK
Portfolio after 10yr
$33.3K
Annual income
$4,401.59/yr
Blended yield
13.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SYK right now

SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
LDOS
Analyst Ratings
18
Buy
9
Hold
Consensus: Buy
Price Target
$211.29
+37.0% upside vs current
Range: $195.00 — $225.00
Altman Z
3.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYK buys
0
LDOS buys
0
No recent congressional trades found for SYK or LDOS in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSYKLDOS
Forward yield1.04%1.08%
Annual dividend / share$3.40$1.66
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.2%15.4%
Portfolio after 10y$43.3K$23.2K
Annual income after 10y$8,282.98$520.20
Total dividends collected$21.0K$2.8K
Payment frequencyquarterlyquarterly
SectorHealthcareIndustrials
Analyst consensusBuyBuy
Analyst price target$428.67$211.29

Year-by-year: SYK vs LDOS ($10,000, DRIP)

YearSYK PortfolioSYK Income/yrLDOS PortfolioLDOS Income/yrGap
1← crossover$10,852$152.43$10,824$124.24+$28.00SYK
2$11,838$226.03$11,727$145.04+$111.00SYK
3$13,004$336.89$12,717$169.47+$287.00SYK
4$14,420$505.63$13,806$198.21+$614.00SYK
5$16,195$766.09$15,004$232.06+$1.2KSYK
6$18,504$1,175.64$16,327$272.01+$2.2KSYK
7$21,635$1,835.40$17,789$319.22+$3.8KSYK
8$26,082$2,932.10$19,409$375.11+$6.7KSYK
9$32,737$4,829.68$21,209$441.40+$11.5KSYK
10$43,312$8,282.98$23,214$520.20+$20.1KSYK

SYK vs LDOS: Complete Analysis 2026

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →

LDOSIndustrials

Leidos Holdings, Inc., together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. It operates through three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S. Intelligence Community, the Department of Defense, the National Aeronautics and Space Administration, military services, and government agencies of U.S. allies abroad, as well as other federal and commercial customers in the national security industry. Its solutions include technology, large-scale systems, command and control platforms, data analytics, logistics, and cybersecurity solutions, as well as intelligence analysis and operations support services to critical missions. The Civil segment provides systems integration services to air navigation service providers, including the federal aviation administration, the En route automation modernization, advanced technology oceanic procedure, time based flow management, terminal flight data management, geo-7, and future flight services, as well as enterprise-information display systems; and security detection and automation services. It also offers information technology (IT) solutions in cloud computing, mobility, application modernization, DevOps, data center, network modernization, asset management, help desk operations, and digital workplace enablement; and environment, energy, and infrastructure services. The Health segment offers solutions to federal and commercial customers responsible for health and well-being of people worldwide, including health information management, managed health, digital transformation, and life sciences research and development services. Leidos Holdings, Inc. was founded in 1969 and is headquartered in Reston, Virginia.

Full LDOS Calculator →
📬

Get this SYK vs LDOS comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYK vs SCHDSYK vs JEPISYK vs OSYK vs KOSYK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.